SCHEMBL14222316

SCHEMBL14222316

CC(=O)c1nc[nH]c1C(=O)Nc1cc(Br)ccc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 5/20 0.54
▸ MAPT P10636 4/20 0.47
▸ ALDH1A1 P00352 7/20 0.47
▸ KMT2A Q03164 7/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ MEN1 O00255 6/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ HPGD P15428 2/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ TDP1 Q9NUW8 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ PKM P14618 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ CYP3A4 P08684 1/20 0.39
▸ APOBEC3A P31941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL215825 0.85 MAPT (0.57) GAAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL213976 0.85 MAPT (0.71) GAAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL215229 0.83 MAPT (0.63) GAAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL215861 0.83 KMT2A (0.63) GAAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL214661 0.82 GAA (0.49) GAAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL213701 0.82 MAPT (0.75) GAAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL213992 0.82 GAA (0.49) GAAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL214708 0.82 GAA (0.49) GAAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL2735397 0.82 GAA (0.49) GAAMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL215408 0.82 GAA (0.49) GAAMAPTALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008042282-A2 IMIDAZOLE-4, 5-DICARBOXAMIDE DERIVATIVES AS JAK-2 MODULATORS EXELIXIS, INC. (US) 2008-04-10 — — WO disclosed
Send feedback